title: Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation.
authors.forename: Elvira
authors.initials: E
authors.lastname: Grandone
authors.forename: Donatella
authors.initials: D
authors.lastname: Colaizzo
authors.forename: Giovanni L
authors.initials: GL
authors.lastname: Tiscia
authors.forename: Patrizia
authors.initials: P
authors.lastname: Vergura
authors.forename: Elena
authors.initials: E
authors.lastname: Chinni
authors.forename: Luigi
authors.initials: L
authors.lastname: Iannaccone
authors.forename: Iole
authors.initials: I
authors.lastname: Antinolfi
authors.forename: Maria A
authors.initials: MA
authors.lastname: Guardascione
authors.forename: Maurizio
authors.initials: M
authors.lastname: Margaglione
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D020767:Intracranial Thrombosis / Q000139:chemically induced / Q000235:genetics; D007558:Italy; D053614:Janus Kinase 2 / Q000235:genetics*; D008641:Mesenteric Vascular Occlusion / Q000139:chemically induced / Q000235:genetics; D008642:Mesenteric Veins; D008875:Middle Aged; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000235:genetics; D011169:Portal Vein; D012307:Risk Factors; D019851:Thrombophilia / Q000150:complications / Q000235:genetics; D054556:Venous Thromboembolism / Q000139:chemically induced / Q000235:genetics; D020246:Venous Thrombosis / Q000139:chemically induced / Q000209:etiology* / Q000235:genetics / Q000401:mortality
chemical_list: D003277:Contraceptives, Oral, Combined; C507924:JAK2 protein, human; D053614:Janus Kinase 2